Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 3/2018

01-12-2018

Prevalence and predictors of atrial arrhythmias in patients with sinus node dysfunction and atrial pacing

Authors: Abdallah Bukari, Eisha Wali, Amrish Deshmukh, Zaid Aziz, Michael Broman, Andrew Beaser, Gaurav Upadhyay, Hemal Nayak, Roderick Tung, Cevher Ozcan

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 3/2018

Login to get access

Abstract

Purpose

This study aimed to determine the incidence, prevalence, and predictors of atrial arrhythmias (AAs) in patients with symptomatic sinus node dysfunction (SND) who required permanent pacemaker implantation. Also, we evaluated the impact of atrial pacing (AP) on AAs.

Methods

All consecutive patients who underwent pacemaker implantation from 2005 to 2011 were included. Atrial fibrillation (AF), atrial flutter (AFL), atrial tachycardia (AT), and AV nodal reentrant tachycardia (AVNRT) were detected via pacemaker interrogation and clinical documentation.

Results

The study group included 322 patients (44% male) with mean age 68.8 ± 15 years and followed for an average of 5.6 ± 2.2 years (median 5.7 years). Overall, 61.8% were found to have any AA at follow-up. Individual prevalence of AAs was high as follows: AF 43.5%, AFL 6.5%, AT 25%, and AVNRT 6.8%. AF was documented in 23% of patients (n = 74) prior to pacemaker; among those, 15% (n = 11) had no recurrence of AF with average AP of 74%. The incidence of new-onset AF after pacemaker was 15.8%. In subgroup analysis, prevalence of AF was increased by 16% with high rate of AP (81–100%) and 17% with lower rate of AP (0–20%). Incidence of new-onset AF was not affected by AP. Diabetes, hypertension, and left atrial enlargement were predictors of AAs. White men and women had higher prevalence of AF.

Conclusions

AAs are highly prevalent in SND, particularly in white patients. Paroxysmal AF is suppressed with AP in minority, but there is no impact of AP on new-onset AF. Patients with diabetes, hypertension, and dilated atria must be monitored closely for early detection of AAs.
Literature
1.
go back to reference Jensen PN, Gronroos NN, Chen LY, Folsom AR, DeFilippi C, Heckbert SR, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol. 2014;64:531–8.CrossRef Jensen PN, Gronroos NN, Chen LY, Folsom AR, DeFilippi C, Heckbert SR, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol. 2014;64:531–8.CrossRef
2.
go back to reference Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13:542–7.CrossRef Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13:542–7.CrossRef
3.
go back to reference John RM, Kumar S. Sinus node and atrial arrhythmias. Circulation. 2016;133:1892–900.CrossRef John RM, Kumar S. Sinus node and atrial arrhythmias. Circulation. 2016;133:1892–900.CrossRef
4.
go back to reference Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114:11–7.CrossRef Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114:11–7.CrossRef
5.
go back to reference Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346:1854–62. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346:1854–62.
6.
go back to reference Said S, Cooper CJ, Alkhateeb H, Gosavi S, Dwivedi A, Onate E, et al. Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode. Med Sci Monit. 2014;20:268–73.CrossRef Said S, Cooper CJ, Alkhateeb H, Gosavi S, Dwivedi A, Onate E, et al. Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode. Med Sci Monit. 2014;20:268–73.CrossRef
7.
go back to reference Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27–e115.CrossRef Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27–e115.CrossRef
8.
go back to reference January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014;2014(130):e199–267. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014;2014(130):e199–267.
9.
go back to reference Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Berlanger A, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840–4.CrossRef Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Berlanger A, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840–4.CrossRef
10.
go back to reference Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD, for the Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 (ENGAGE AF-TIMI 48) Echocardiographic Study Investigators Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J 2014; 35:1457–1465. Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD, for the Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 (ENGAGE AF-TIMI 48) Echocardiographic Study Investigators Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J 2014; 35:1457–1465.
11.
go back to reference Healey JS, Martin JL, Duncan A, Connolly SJ, Ha AH, Morillo CA, et al. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol. 2013;29:224–8.CrossRef Healey JS, Martin JL, Duncan A, Connolly SJ, Ha AH, Morillo CA, et al. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol. 2013;29:224–8.CrossRef
12.
go back to reference Tse HF, Lau CP. Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome. Heart. 2005;91:362–4.CrossRef Tse HF, Lau CP. Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome. Heart. 2005;91:362–4.CrossRef
13.
go back to reference Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. Pacing Clin Electrophysiol. 1998;21:250–5.CrossRef Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. Pacing Clin Electrophysiol. 1998;21:250–5.CrossRef
14.
go back to reference Horvath G, Goldberger JJ, Kadish AH. Simultaneous occurrence of atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol. 2000;11:849–58.CrossRef Horvath G, Goldberger JJ, Kadish AH. Simultaneous occurrence of atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol. 2000;11:849–58.CrossRef
15.
go back to reference Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter. Mechanisms and Clinical Implications. J Am Coll Cardiol. 2008;51:779–86.CrossRef Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter. Mechanisms and Clinical Implications. J Am Coll Cardiol. 2008;51:779–86.CrossRef
16.
go back to reference Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation. 1994;89:724–30.CrossRef Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation. 1994;89:724–30.CrossRef
17.
go back to reference Kamel H, Kleindorfer DO, Bhave PD, Cushman M, Levitan EB, Howard G, et al. Rates of atrial fibrillation in black versus white patients with pacemakers. J Am Heart Assoc. 2016;5:1–7.CrossRef Kamel H, Kleindorfer DO, Bhave PD, Cushman M, Levitan EB, Howard G, et al. Rates of atrial fibrillation in black versus white patients with pacemakers. J Am Heart Assoc. 2016;5:1–7.CrossRef
18.
go back to reference Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111–7.CrossRef Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111–7.CrossRef
19.
go back to reference Hjortshøj S, Riahi S, Nielsen JC, Skjøth F, Lundbye-Christensen S, Andersen HR. Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial. Europace. 2014;16:241–5.CrossRef Hjortshøj S, Riahi S, Nielsen JC, Skjøth F, Lundbye-Christensen S, Andersen HR. Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial. Europace. 2014;16:241–5.CrossRef
20.
go back to reference Elkayam L, Koehler J, Sheldon T, Glotzer T, Rosenthal L, Lamas G. The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis. PACE. 2011;34:1593–9.CrossRef Elkayam L, Koehler J, Sheldon T, Glotzer T, Rosenthal L, Lamas G. The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis. PACE. 2011;34:1593–9.CrossRef
21.
go back to reference Monfredi O, Boyett MR. Sick sinus syndrome and atrial fibrillation in older persons — a view from the sinoatrial nodal myocyte. J Mol Cell Cardiol. 2015;83:88–100.CrossRef Monfredi O, Boyett MR. Sick sinus syndrome and atrial fibrillation in older persons — a view from the sinoatrial nodal myocyte. J Mol Cell Cardiol. 2015;83:88–100.CrossRef
22.
go back to reference Inohara T, Shrader P, Pieper K, Blanco R, Thomas L, Singer D, et al. Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes. JAMA Cardiol. 2018;3:54–63.CrossRef Inohara T, Shrader P, Pieper K, Blanco R, Thomas L, Singer D, et al. Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes. JAMA Cardiol. 2018;3:54–63.CrossRef
23.
go back to reference Chen Y, Bai R, Lin T, Salim M, Sang C, Long D, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37:403–11.CrossRef Chen Y, Bai R, Lin T, Salim M, Sang C, Long D, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37:403–11.CrossRef
24.
go back to reference Khaykin Y, Marrouche N, Martin D, Saliba W, Schweikert R, Wexman M, et al. Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses. J Cardiovasc Electrophysiol. 2004;15:784–9.CrossRef Khaykin Y, Marrouche N, Martin D, Saliba W, Schweikert R, Wexman M, et al. Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses. J Cardiovasc Electrophysiol. 2004;15:784–9.CrossRef
25.
go back to reference Hocini M, Sanders P, Deisenhofer I, Jaïs P, Hsu LF, Scavée C, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108:1172–5.CrossRef Hocini M, Sanders P, Deisenhofer I, Jaïs P, Hsu LF, Scavée C, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108:1172–5.CrossRef
26.
go back to reference Jackson LR, Rathakrishnan B, Campbell K, Thomas KL, Piccini JP, Bahnson T, et al. Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? PACE. 2017;40:442–50.CrossRef Jackson LR, Rathakrishnan B, Campbell K, Thomas KL, Piccini JP, Bahnson T, et al. Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? PACE. 2017;40:442–50.CrossRef
Metadata
Title
Prevalence and predictors of atrial arrhythmias in patients with sinus node dysfunction and atrial pacing
Authors
Abdallah Bukari
Eisha Wali
Amrish Deshmukh
Zaid Aziz
Michael Broman
Andrew Beaser
Gaurav Upadhyay
Hemal Nayak
Roderick Tung
Cevher Ozcan
Publication date
01-12-2018
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 3/2018
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0463-7

Other articles of this Issue 3/2018

Journal of Interventional Cardiac Electrophysiology 3/2018 Go to the issue